Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Drugs of Today (Barcelona, Spain : 1998)
|
February 28, 2004
Vascular endothelial growth factor and its inhibitors
H M W Verheul, H M Pinedo
The Journal of Pathology
|
December 25, 2003
Are tumours angiogenesis-dependent?
H M W Verheul, E E Voest, R O Schlingemann
Current Pharmaceutical Design
|
July 18, 2006
Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology
C Verhoef, J H W de Wilt, H M W Verheul
Current Oncology (Toronto, Ont.)
|
November 23, 2018
Are patient-reported outcomes of physical function a valid substitute for objective measurements?
J A J Douma, H M W Verheul, L M Buffart
The Netherlands Journal of Medicine
|
March 25, 2009
Systemic treatment in hepatocellular carcinoma; 'A small step for man...'
C D M Witjes, C Verhoef, H M W Verheul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2009
Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib
E N M Overkleeft, R Goldschmeding, F van Reekum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 27, 2014
Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: a systematic review
K S Versteeg, I R Konings, A M Lagaay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
'Pre-cachexia': a non-existing phenomenon in cancer?
S Blauwhoff-Buskermolen, M A E de van der Schueren, H M W Verheul, et al.
Angiogenesis
|
December 29, 2010
Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review
Maudy Walraven, Petronella O Witteveen, Martijn P J Lolkema, et al.
Cancer Epidemiology
|
December 15, 2015
What is the benefit of treatment with multiple lines of chemotherapy for patients with metastatic breast cancer? A retrospective cohort study
J L Bakker, K Wever, J H van Waesberghe, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Drugs of Today (Barcelona, Spain : 1998)
|
February 28, 2004
Vascular endothelial growth factor and its inhibitors
H M W Verheul, H M Pinedo
The Journal of Pathology
|
December 25, 2003
Are tumours angiogenesis-dependent?
H M W Verheul, E E Voest, R O Schlingemann
Current Pharmaceutical Design
|
July 18, 2006
Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology
C Verhoef, J H W de Wilt, H M W Verheul
Current Oncology (Toronto, Ont.)
|
November 23, 2018
Are patient-reported outcomes of physical function a valid substitute for objective measurements?
J A J Douma, H M W Verheul, L M Buffart
The Netherlands Journal of Medicine
|
March 25, 2009
Systemic treatment in hepatocellular carcinoma; 'A small step for man...'
C D M Witjes, C Verhoef, H M W Verheul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2009
Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib
E N M Overkleeft, R Goldschmeding, F van Reekum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 27, 2014
Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: a systematic review
K S Versteeg, I R Konings, A M Lagaay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
'Pre-cachexia': a non-existing phenomenon in cancer?
S Blauwhoff-Buskermolen, M A E de van der Schueren, H M W Verheul, et al.
Angiogenesis
|
December 29, 2010
Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review
Maudy Walraven, Petronella O Witteveen, Martijn P J Lolkema, et al.
Cancer Epidemiology
|
December 15, 2015
What is the benefit of treatment with multiple lines of chemotherapy for patients with metastatic breast cancer? A retrospective cohort study
J L Bakker, K Wever, J H van Waesberghe, et al.
Page
of 5